Technology Industry
Industry: Email Alert RSS FeedInspire Raises $9.9m More After Ipo
BT Catalyst, Oct, 2000
Inspire Pharmaceuticals Inc. (Nasdaq: ISPH) of Durham has raised an additional $9.9 million over the $66 million raised during its initial public offering of common stock in August.
The additional funds are the result of an overallotment option exercised by the underwriters of the IPO. The underwriters purchased an additional 825,000 shares at a price of $12 per share, bringing the total shares of Inspire common stock offered and sold to 6,325,000.
Chase H&Q of Baltimore, U.S. Bancorp Piper Jaffray of Minneapolis, Minn., and Deutsche Banc Alex. Brown, a subsidiary of Deutsche Bank of Frankfurt, Germany, were the underwriters for the offering.
- Most Popular Articles in Technology
- An overview of continuous data protection
- Why all those current ratings?
- Many countries now have a mobile penetration rate above 100%, report says
- The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...
- MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...
- More »
Inspire discovers and develops new drugs to treat diseases characterized by deficiencies in the body's innate defense mechanisms. The company currently has three product candidates in advanced clinical development.
COPYRIGHT 2000 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning